AnaptysBio adds strategic collaboration with another leading global pharmaceutical company

San Diego, Calif. - 1 March 2010

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a strategic collaboration with an undisclosed leading global pharmaceutical company to generate novel antibody therapeutics to a specified disease target. This is the third collaboration with a leading pharmaceutical company announced by AnaptysBio during 2010.

Click here to read AnaptysBio's press release.